Trulicity 3 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FEZA6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,034
Award facts
- Contract value 100% obligated
- $17,033.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,033.75 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed-price delivery order represents a pediatric or standard dosage diabetes medication procurement without any set-aside designation, indicating competitive award status. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to supply medications and medical commodities to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated significant capability in fulfilling federal medical procurement requirements through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency. The company serves critical healthcare needs for military and veteran systems, including the Defense Health Agency and U.S. Coast Guard, providing a broad spectrum of pharmaceutical products ranging from diabetes medications to specialty treatments. This delivery order exemplifies the company's role as a primary vendor in the DLA's medical supply chain, supporting the agency's mission to provision medications and medical supplies for defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FEZA6?
SPE2DB25FEZA6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FEZA6 worth?
The government has obligated $17,034 on SPE2DB25FEZA6.
Is contract SPE2DB25FEZA6 an order under another contract?
Yes. SPE2DB25FEZA6 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FEZA6 competed?
The extent of competition for SPE2DB25FEZA6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award